إعلان مُمول
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
نشر بتاريخ
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
البحث
الأقسام
- National
- International
- Business
- Technology
- Health
- التعليم
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
إقرأ المزيد
Vijay Deverakonda on privacy: "If I could wear a mask, I would"
Vijay Deverakonda acknowledges the challenges of balancing fame and privacy, expressing a desire...
RSP and RPP boycott Parliament over lack of high-level probe into visit visa scandal
KATHMANDU: The Rastriya Swatantra Party (RSP) and Rastriya Prajatantra Party (RPP) boycotted...
EXCLUSIVE | Akash Deep got England squad inclusion news while at hospital with cancer-stricken sister
Akash Deep dedicated India's Edgbaston Test victory to his sister, who is battling cancer....
Landslide blocks Myagdi River, authorities urge caution
MYAGDI: A landslide in Dhaulagiri Rural Municipality–4 of Myagdi district has blocked the...